Table 1.
Baseline clinical characteristics of study population (n = 104).
| Variable | Value (%) |
|---|---|
| Age, years | 44 ± 13 |
| Male gender, N (%) | 89 (86) |
| Hypertension, N (%) | 50 (48) |
| Diabetes mellitus, N (%) | 6 (6) |
| Hyperlipidemia, N (%) | 29 (28) |
| Smoker, N (%) | 14 (13) |
| Coronary artery disease, N (%) | 4 (4) |
| Previous cardiac surgery, N (%) | 4 (4) |
| Stroke, N (%) | 1 (1) |
| NYHA Class I, N (%) | 104 (100) |
| Height, cm | 180 ± 9 |
| Weight, kg | 85 ± 14 |
| Systolic blood pressure, mmHg | 136 ± 16 |
| Diastolic blood pressure, mmHg | 70 ± 12 |
| Heart rate, beats per min | 64 ± 10 |
| B natriuretic peptide, ng/L | 27 (42) |
| Hemoglobin, g/L | 153 ± 13 |
Values are means ± standard deviations, median (interquartile range), or numbers (percentage). ACEI/ARB: angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, NYHA: New York Heart Association.